Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Multiple Myeloma 28Breast Neoplasms 23Neoplasms 21Pancreatic Neoplasms 17Glioma 17Prostatic Neoplasms 16Glioblastoma 16Recurrence 14Leukemia, Myeloid, Acute 14Solid Tumor 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Non-Hodgkin 12Brain Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Lung Neoplasms 9Triple Negative Breast Neoplasms 8Melanoma 8Lymphoma 8Hematologic Neoplasms 8Lymphoma, B-Cell 7Colorectal Neoplasms 7Polycystic Ovary Syndrome 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Advanced Solid Tumors 6Sarcoma 5Myelodysplastic Syndromes 5Leukemia, Plasma Cell 5

Interventions

2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Recruiting × Pituitary ACTH Hypersecretion × Clear all
NCT07460232 2026-05-29

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

Mayo Clinic

Phase EARLY_PHASE1 Recruiting
50 enrolled
Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡